Business Context and Reporting Period
This Form 8-K Current Report was filed by SBC Medical Group Holdings Inc on November 13, 2025. The filing discloses a strategic corporate action involving the Company's wholly owned subsidiary, SBC Medical Group Co., Ltd. ("SBCMG"), and a Japanese corporation listed on the Tokyo Stock Exchange Growth Market, Waqoo, Inc. ("Waqoo").
Key Financial Metrics and Transaction Details
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. Instead, it details the following transaction-specific data:
- Current Ownership: SBCMG currently owns 353,600 shares of Waqoo, representing approximately 9.49% of outstanding shares.
- CEO Ownership: Dr. Yoshiyuki Aikawa, the Company's CEO, personally holds 989,802 shares of Waqoo, representing approximately 26.58% of outstanding shares.
- Tender Offer Size: SBCMG intends to acquire up to 575,000 shares of Waqoo common stock.
- Offer Price: The price per share is to be determined and is not specified in this filing.
- Transaction Timeline: The tender offer runs from November 14, 2025, through December 12, 2025, with expected settlement on December 19, 2025.
Material Changes and Strategic Actions
The Board of Directors of SBCMG approved the commencement of a tender offer for Waqoo shares. Concurrently, an off-market transfer has been structured where SBCMG will acquire all 989,802 shares held by Dr. Aikawa, subject to the settlement of the tender offer. Upon completion of these transactions, SBCMG intends to consolidate Waqoo as a subsidiary, integrating it into the Company's consolidated group.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding product launch plans, revenue growth, and business prospects. Management cautions that these statements are not guarantees and are subject to risks including changes in global economic conditions, regulatory environments, and competitive markets. The filing explicitly states that the Company does not undertake an obligation to update these forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the final price per share for the tender offer once determined.
- Confirm the total number of shares tendered by public shareholders during the offer period.
- Monitor the successful execution of the off-market share transfer from Dr. Aikawa.
- Review the final consolidation status of Waqoo, Inc. post-settlement.
- Check for any regulatory approvals required for the acquisition in Japan or the U.S.